logo

SLN

Silence Therapeutics·NASDAQ
--
--(--)
--
--(--)

SLN fundamentals

Silence Therapeutics (SLN) released its earnings on Nov 6, 2025: revenue was 159.00K (YoY -89.04%), missed estimates; EPS was -0.15 (YoY +38.20%), beat estimates.
Revenue / YoY
159.00K
-89.04%
EPS / YoY
-0.15
+38.20%
Report date
Nov 6, 2025
EPS
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
-0.1054-0.1572-0.08410.4524-0.1184-0.1224-0.0922-0.1587-0.0177-0.1427-0.2427-0.2-0.19-0.15
Forecast
-0.1908-0.1961-0.2011-0.0124-0.1504-0.1729-0.1719-0.08-0.1203-0.114-0.1275-0.1508-0.1325-0.1871
Surprise
0.00%
+44.76%
+19.84%
+58.18%
+3748.39%
+21.28%
+29.21%
+46.36%
-98.38%
+85.29%
-25.18%
-90.35%
0.00%
-32.63%
-43.40%
+19.83%
Revenue
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
--6.98M4.33M3.94M17.83M14.18M11.61M3.49M2.69M15.72M768.58K1.45M--142.00K224.00K159.00K
Forecast
--00020.37M3.14M3.81M2.92M8.88M6.32M11.82M5.69M--5.20M7.03M4.38M
Surprise
0.00%
0.00%
0.00%
0.00%
-12.47%
+351.25%
+204.67%
+19.56%
-69.66%
+148.74%
-93.50%
-74.51%
0.00%
-97.27%
-96.81%
-96.37%

Earnings Call